Molecular Diagnostics
A Liquid Biopsy Approach for Predicting Likely Relapse Following Treatment of Medulloblastoma in Children
A liquid biopsy technique that determines the level of cell-free DNA in cerebrospinal fluid (CSF) can be used to detect measurable residual disease (MRD) in children being treated for the malignant brain tumor medulloblastoma. More...02 Nov 2021
Gene Expression Test Improves Idiopathic Pulmonary Fibrosis Diagnosis
Idiopathic pulmonary fibrosis (IPF) is a serious chronic disease that affects the tissue surrounding the air sacs, or alveoli, in the lungs. This condition occurs when that lung tissue becomes thick and stiff for undetermined reasons. More...01 Nov 2021
Cyclic Adenosine Monophosphate (cAMP) May Be a Diagnostic Biomarker for Chronic Respiratory Diseases
Levels of cyclic adenosine monophosphate in the blood are higher in asthma and chronic obstructive pulmonary disease (COPD) patients and may be a diagnostic biomarker for these disorders. More...01 Nov 2021
Bio-Rad Launches New CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics
Bio-Rad Laboratories Inc. (Hercules, CA, USA) has launche the CFX Opus 96 Dx System and the CFX Opus 384 Dx System, real-time PCR detection systems that have been listed with the US Food and Drug Administration (FDA) for IVD testing and that meet the CE-IVD requirement for IVD use in Europe. More...01 Nov 2021
![Image: A cancer cell during cell division (Photo courtesy of [U.S.] National Institutes of Health)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2021-10-26/GMS-082B.jpg "Image: A cancer cell during cell division (Photo courtesy of [U.S.] National Institutes of Health)")
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Alcohol Testing Device
Dräger Alcotest 7000
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
In Other News
Next Generation Sequencing (NGS)-Based Breast Cancer Monitoring Test Could Aid Timely Treatment Decisions
Blood Test Combines Cutting-Edge Genomics and AI to Identify Persistent or Recurrent Cancer
Revolution in Rapid Testing: A New Generation of Programmable Lateral Flow Assays
Non-Invasive Nasal Swab Test Leverages Advanced Genomic Technology to Detect Lung Cancer Risk
Low Anti-SARS-CoV-2 S Antibody Levels Predict Increased Mortality
Biohit’s Innovative GastroPanel Quick Test Receives CE Mark
Fecal Immunochemical Tubes Sourced to Analyze Gut Microbiome for CRC
First-of-Its-Kind Testing Device Allows For Rapid Detection of Bacteria That Identify Risk for Preterm Birth
Mutation Analysis Links Angioimmunoblastic T-Cell Lymphoma to Clonal Hematopoiesis
Unique Gene Detects Mycobacterium Tuberculosis in Clinical Sputum
Whole-Genome Sequencing Applied to Acutely Ill Infants
High Cell-Free DNA Integrity Is a Biomarker for Poor Breast Cancer Survival
Elevated Circulating Fatty Acid Synthase Is a Diagnostic Biomarker for Peripheral Artery Disease
Meridian Launches New Air-Dryable qPCR Mix Enabling Direct Detection of RNA from Whole Blood Samples
ALPK3 Truncating Variants Cause Autosomal Dominant Hypertrophic Cardiomyopathy
PCR Assay Detects and Differentiates Coccidioides Species
Next-Generation Multiomics Blood-Based Test for Pancreatic Cancer Could Become Powerful Tool for Early Diagnosis and Treatment
Liquid Biopsy Test Tracks Treatment-Based ctDNA Changes
New State-of-the-Art, Ultrasensitive Blood Test to Transform Detection of Brain Damage and Poor Prognosis After Head Injury
A Blood-Based Liquid Biopsy Combined with Machine Learning for Early Lung Cancer Diagnosis
Benign Hypertension-Causing Tumors Linked to Somatic Co-Driver Mutations
WHO Warning: Rapid Tests Misdiagnose Many Cases of P. falciparum Malaria in Africa
Next Generation Rapid Antibiotic Susceptibility Testing (AST) Platform Granted FDA Breakthrough Device Designation
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.